CannMed Coffee Talk Podcast Por Medicinal Genomics arte de portada

CannMed Coffee Talk

CannMed Coffee Talk

De: Medicinal Genomics
Escúchala gratis

Acerca de esta escucha

 Conversations with the leading minds in cannabis science, medicine, cultivation, and safety testing. Ciencia Ciencias Biológicas Historia Natural Hygiene & Healthy Living Naturaleza y Ecología
Episodios
  • Wrapping Up CannMed 25

    Wrapping Up CannMed 25
    Jun 25 2025
    Another CannMed Summit is in the books. To all of you who joined us in Puerto Rico this year, thank you for making it our best event yet! This year’s summit brought together clinicians, regulators, researchers, cultivators, patients, and entrepreneurs from more than a dozen countries. The enthusiasm and passion that they brought to the sessions and the networking events created an amazing environment for creating lasting connections. We can’t wait to see how those connections shape the future of the industry. If you weren’t able to join us this year, don’t worry, you can experience at least part of the CannMed magic when we post video recordings of all the panels and oral presentations on our YouTube page and the CannMed Archive. Those will be posted in the next 30-45 days. Be sure to sign up for email alerts to receive an email when they are live. We are already looking forward to CannMed 26 and will hopefully have details to share very soon. 2026 is the 10 year anniversary of our very first event, so we are working on some special ways to celebrate. That’s it for now. No interview today. We are still resetting following the event, but we should be back with a new episode for July 9th.
    Más Menos
    3 m
  • The Impact of Cannabinoids on Prostate Cancer with Shiksha Gallow, MD

    The Impact of Cannabinoids on Prostate Cancer with Shiksha Gallow, MD
    Jun 11 2025
    Dr. Shiksha Gallow currently serves as the Medical Director of the Holistic Integrative Healing Institute and is notably the first and only South African to sit on the Board of Directors of the Society of Cannabis Clinicians. Dr. Gallow’s passion lies in leveraging her medical and scientific expertise to develop Active Pharmaceutical Ingredients (APIs) from cannabis and other plant species to treat various conditions. She has achieved significant success in treating patients with autoimmune diseases and cancer, and she strongly advocates for patient access to safe and effective medicines that improve quality of life. At CannMed 25 she will present “Comprehensive Evaluation of the ‘Impact of Cannabinoids’ on Prostate Cancer: Integrating PSA, PET/CT Scans and Patient-Related Outcomes” During our conversation we discuss The variety of treatment options for prostate cancer and the role of cannabinoids may play Results from an empirical study that evaluated how cannabinoid treamtment impacts PSA levels PET/CT scans and patient reported outcomes How patients were selected and grouped for the study Future research opportunities and more Thanks to This Episode's Sponsor: PRICH Biotech PRICH Biotech, Corp. is a vertically integrated company dedicated to the cultivation, manufacture and dispensing of medicinal Cannabis in Puerto Rico. With over 500,000 square feet of STATE OF THE ART facilities, Prich uses the highest standards of agricultural and manufacturing practices to Guarantee the highest standard of medicinal cannabis. Their mission is to offer a natural and unique experience through medicinal cannabis that raises the patient's well-being and quality of life. Learn more at prichbiotech.com. Additional Resources Dr. Gallow on Linkedin Holistic Healing Dr Gallow (Facebook) CannMed Video Archives
    Más Menos
    33 m
  • The Science of Cannabis Safety Testing with Morgan Keefer

    The Science of Cannabis Safety Testing with Morgan Keefer
    May 28 2025
    Morgan Keefer is the Senior Accreditation Officer at A2LA where she works with and assesses cannabis testing laboratories across the United States. Since joining A2LA, Morgan has presented about Laboratory Shopping, Proficiency Testing, and Microbial Testing in the cannabis industry at Cannabis Science Conference, A2LA's Annual Conference and PITTCON. At CannMed 25 she will present “Accredited Methods in Cannabis Testing” which will explore many of the challenges facing cannabis testing labs. During our conversation we discuss: The variation of cannabis testing regulations across the U.S., and how that creates challenges for multi-state labs and manufacturers. The lack of established testing standards, which leads to inconsistent results across the industry The role organizations like AOAC and USP play in creating standard methods How inconsistent testing results affect consumer safety The lack of testing requirements for consumable hemp products Thank You to This Episode’s Sponsor: McKinney RSA McKinney is made up of regulatory science veterans who apply lessons learned in the nicotine space to help cannabis manufacturers better understand the toxicological and societal implications of their product. They do that by Identifying base compounds, extracts, flavors and terpenes, understanding how they interact, and ensuring effectiveness for the intended use. They also provide dosing recommendations and establish guidelines for product consistency. Learn more at mckinneyrsa.com Additional Resources NIHC Verify program A2LA-NIHC Verify Hemp/Cannabis Recognition Program A2LA Domestic Recognitions A2LA Public Documents Register for CannMed 25 Meet the CannMed 25 Speakers and Poster Presenters Review the Podcast CannMed Archive
    Más Menos
    50 m
Todavía no hay opiniones